On December 20, 2017 Vectura Group plc (LSE: VEC) ("Vectura", "the Company"), an industry-leading device and formulation business for inhaled airways products, reported that James Ward-Lilley, Chief Executive Officer, will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco, on Wednesday, 10 January 2018, at 9:30am PST / 17:30pm GMT (Press release, Vectura, DEC 20, 2017, View Source;customerKey=VecturaIntranet&storyID=13758359 [SID1234522731]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentation and a copy of the slides will be available on the Company’s website: View Source A recording will be available following the presentation.

Vectura will issue a 2017 pre-close trading update on Thursday 4th January 2018.

– Ends –

Enquiries

Vectura Group plc

+44 (0)1249 667700

Elizabeth Knowles – Director Investor Relations and Analysis

David Ginivan – VP Corporate Communications

Consilium Strategic Communications

+44 (0)20 3709 5700

Mary-Jane Elliott / Chris Welsh / Jessica Hodgson